5 year targets
Hastim is today at a major turning point in its development with an ambitious five-year strategic plan to lead to the confirmation in humans of the conclusions obtained in animal health
![](https://www.hastim.fr/build/images/element-float-01.png)
![Seringue dans flacon vaccin](/storage/fm_files/hastim/biotech/bt3.jpg)
Benefiting from a proven decline and demonstrated results in Animal Health, we are starting an operational phase in Human Health.
The start of a collaboration with the INSERM 1231 unit aims to complete pre-clinical exploration and to stimulate the start of clinical trials in oncological haematology.